-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QEmz2nl1m11JsShMK0LO0aNZJBdDPn7gS3KIeozGIocztvjzpgcfjNpmeLodAWnP Zm6fgdw+FUB1+uA8KzkIow== 0000898822-96-000114.txt : 19960411 0000898822-96-000114.hdr.sgml : 19960411 ACCESSION NUMBER: 0000898822-96-000114 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960410 SROS: NYSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: CARDINAL HEALTH INC CENTRAL INDEX KEY: 0000721371 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 310958666 STATE OF INCORPORATION: OH FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-11373 FILM NUMBER: 96545578 BUSINESS ADDRESS: STREET 1: 5555 GLENDON COURT CITY: DUBLIN STATE: OH ZIP: 43016 BUSINESS PHONE: 6147618700 MAIL ADDRESS: STREET 1: 655 METRO PLACE SOUTH STREET 2: SUITE 925 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: CARDINAL DISTRIBUTION INC DATE OF NAME CHANGE: 19920703 DEFA14A 1 SCHEDULE 14A SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) FILED BY THE REGISTRANT [X] FILED BY A PARTY OTHER THAN THE REGISTRANT [ ] CHECK THE APPROPRIATE BOX: [ ] PRELIMINARY PROXY STATEMENT [ ] CONFIDENTIAL, FOR USE [ ] DEFINITIVE PROXY STATEMENT OF THE COMMISSION ONLY [X] DEFINITIVE ADDITIONAL MATERIALS [ ] SOLICITING MATERIAL PURSUANT TO RULE 14A-11(C) OR RULE 14A-12 CARDINAL HEALTH, INC. .............................................................. (NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) N/A ............................................................... (NAME OF PERSON(S) FILING PROXY STATEMENT, IF OTHER THAN THE REGISTRANT) PAYMENT OF FILING FEE (CHECK THE APPROPRIATE BOX): [ ] $125 PER EXCHANGE ACT RULES 0-11(C)(1)(II), 14A-6(I)(1), OR 14A-6(I)(2) OR ITEM 22(A)(2) OF SCHEDULE 14A. [ ] $500 PER EACH PARTY TO THE CONTROVERSY PURSUANT TO EXCHANGE ACT RULE 14A-6(I)(3). [ ] FEE COMPUTED ON TABLE BELOW PER EXCHANGE ACT RULES 14A-6(I)(4) AND 0-11. 1) TITLE OF EACH CLASS OF SECURITIES TO WHICH TRANS- ACTION APPLIES: 2) AGGREGATE NUMBER OF SECURITIES TO WHICH TRANSACTION APPLIES: 3) PER UNIT PRICE OR OTHER UNDERLYING VALUE OF TRANS- ACTION COMPUTED PURSUANT TO EXCHANGE ACT RULE 0-11: 4) PROPOSED MAXIMUM AGGREGATE VALUE OF TRANSACTION: 5) TOTAL FEE PAID: [X] FEE PAID PREVIOUSLY WITH PRELIMINARY MATERIALS. [ ] CHECK BOX IF ANY PART OF THE FEE IS OFFSET AS PROVIDED BY EXCHANGE ACT RULE 0-11(A)(2) AND IDENTIFY THE FILING FOR WHICH THE OFFSETTING FEE WAS PAID PREVIOUSLY. IDENTIFY THE PREVIOUS FILING BY REGISTRATION STATEMENT NUMBER, OR THE FORM OR SCHEDULE AND THE DATE OF ITS FILING. 1) AMOUNT PREVIOUSLY PAID: ............................ 2) FORM, SCHEDULE OR REGISTRATION STATEMENT NO.: ............................ 3) FILING PARTY: ............................ 4) DATE FILED: ............................ [Letterhead of Cardinal Health, Inc.] NEWS RELEASE FOR IMMEDIATE RELEASE APRIL 9, 1996 CONTACT: Debra Dendahl Hadley Director, Investor Relations (614) 717-7481 CARDINAL HEALTH DENIES RUMOR ABOUT FOXMEYER DUBLIN, OHIO, APRIL 9, 1996 -- Cardinal Health, Inc. (NYSE: CAH) announced today that, contrary to recent press reports, it is not in discussions or negotiations with respect to the purchase of FoxMeyer Health Corporation's drug distribution business. "Although it is Cardinal's standard policy not to comment on market rumors, we felt that it was necessary in this case to set the record straight in light of the upcoming Cardinal and Pyxis special shareholders' meetings to be held on April 26," stated Robert D. Walter, chairman and chief executive officer of Cardinal Health, Inc. At the special meetings, shareholders of both Cardinal Health, Inc. and Pyxis Corporation will vote on a proposal to approve and adopt an Agreement and Plan of Merger, dated as of February 7, 1996, pursuant to which Pyxis will become a wholly-owned subsidiary of Cardinal. Cardinal Health, Inc., based in Dublin, Ohio, is one of the country's largest pharmaceutical distributors. The company provides an array of innovative, value-added services to a broad base of customers nationwide including hospitals, independent and chain pharmacies, managed care facilities, alternate care centers, and the pharmacy departments of supermarkets and mass merchandisers. The company is also a franchisor of apothecary-style pharmacies through its wholly- owned subsidiary, Medicine Shoppe International, Inc. ### -----END PRIVACY-ENHANCED MESSAGE-----